Karl Naegler is a Partner at Sofinnova Partners with over 20 years of life sciences investment experience. He started his career with Atlas Ventures and held senior roles at Wellington Partners and Gimv, backing companies such as Seamless Therapeutics, Breath Therapeutics, Covagen and Prosonix. Karl holds a PhD in Molecular Neurobiology and has served as a board member and advisor to several leading biotech startups.